Home  /  Resource Library  /  Treatment with obinutuzumab leads to worse outcomes in haematological patients diagnosed with Omicron variant COVID-19

Treatment with obinutuzumab leads to worse outcomes in haematological patients diagnosed with Omicron variant COVID-19

Study investigated outcomes of COVID-19 patients with lymphoma treated with Obinutuzumab or Rituximab.